ST
MNTA

Spot Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Spot Trading’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,600
Closed -$190K – 4251
2015
Q3 		$190K Buy
+11,600
New +$237K ﹤0.01% 2724
2014
Q4 		– Sell
-56,100
Closed -$636K – 4562
2014
Q3 		$636K Buy
56,100
+4,900
+10% +$55.9K ﹤0.01% 2389
2014
Q2 		$618K Sell
51,200
-12,800
-20% -$151K ﹤0.01% 2522
2014
Q1 		$746K Sell
64,000
-22,100
-26% -$374K ﹤0.01% 2232
2013
Q4 		$1.52M Buy
86,100
+41,400
+93% +$696K 0.01% 1689
2013
Q3 		$643K Buy
44,700
+14,800
+49% +$227K ﹤0.01% 2251
2013
Q2 		$450K Buy
+29,900
New +$395K ﹤0.01% 2515

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spot Trading's MNTA Position: Q4 2014 in Review

Spot Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2014, closing a stake of 192 shares — an estimated $2K sold.

Spot Trading first reported a position in MNTA in Q2 2013 and held it in 6 quarters. The position peaked at $1.35M in Q1 2014. 148 funds tracked by Wall St. Rank hold MNTA as of Q4 2014.

  • Spot Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 192 Momenta Pharmaceuticals, Inc. shares in Q4 2014, an estimated $2K.
  • Spot Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
  • Spot Trading's Momenta Pharmaceuticals, Inc. position peaked at $1.35M in Q1 2014.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.